Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
2.23%
operating margin TTM
5.52%
revenue TTM
406.35 Million
revenue per share TTM
3.18$
valuation ratios | |
|---|---|
| pe ratio | 113.97 |
| peg ratio | -2.22 |
| price to book ratio | 6.89 |
| price to sales ratio | 2.58 |
| enterprise value multiple | 36.71 |
| price fair value | 6.89 |
profitability ratios | |
|---|---|
| gross profit margin | 89.77% |
| operating profit margin | 5.52% |
| pretax profit margin | 2.4% |
| net profit margin | 2.23% |
| return on assets | 2.08% |
| return on equity | 8.2% |
| return on capital employed | 7.37% |
liquidity ratios | |
|---|---|
| current ratio | 3.14 |
| quick ratio | 2.70 |
| cash ratio | 1.45 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 506.74 |
| operating cycle | 639.91 |
| days of payables outstanding | 201.90 |
| cash conversion cycle | 438.01 |
| receivables turnover | 2.74 |
| payables turnover | 1.81 |
| inventory turnover | 0.72 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 1.31 |
| long term debt to capitalization | 0.50 |
| total debt to capitalization | 0.57 |
| interest coverage | 1.25 |
| cash flow to debt ratio | 0.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.36 |
| cash per share | 3.71 |
| operating cash flow per share | 0.36 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.09 |
| short term coverage ratios | 0.45 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) reported earnings?
Apellis Pharmaceuticals, Inc. (APLS) published its most recent earnings results on 30-10-2025.
What is Apellis Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)'s trailing twelve months ROE is 8.2%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Apellis Pharmaceuticals, Inc. (APLS) currently has a ROA of 2.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did APLS's net profit margin stand at?
APLS reported a profit margin of 2.23% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is APLS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.14 in the most recent quarter. The quick ratio stood at 2.70, with a Debt/Eq ratio of 1.31.